REFERENCES
- American Lung Association. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet (Chronic Bronchitis and Emphysema), American Lung Association 2005 July [cited 2006 Mar 6]; http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=35020
- American Lung Association Epidemiology & Statistics Unit Research and Program Services. Trends in Chronic Bronchitis and Emphysema: Morbidity and Mortality. American Lung Association. 2005
- National Institutes of Health, National Heart, Lung, and Blood Institute. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop. 2004
- Mapel D W, McMillan G P, Frost F J, Hurley J S, Picchi M A, Lydick E, et al. Predicting the costs of managing patients with chronic obstructive pulmonary disease. Respir Med 2005; 99(10)1325–1333, [INFOTRIEVE], [CSA]
- Tinkelman D G, George D, Halbert R J. Chronic obstructive pulmonary disease in patients under age 65: utilization and costs from a managed care sample. J Occup Environ Med 2005; 47(11)1125–1130, [INFOTRIEVE], [CROSSREF], [CSA]
- Marton J P, Boulanger L, Friedman M, Dixon D, Wilson J, Menzin J. Assessing the costs of chronic obstructive pulmonary disease: the state Medicaid perspective. Respir Med 2006; 100(6)996–1005, [INFOTRIEVE], [CROSSREF], [CSA]
- Miller J D, Foster T, Boulanger L, Chace M, Russell M W, Marton J P, et al. Direct costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data. COPD 2005; 2(3)311–318, [CSA]
- National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Heart, Lung, and Blood Institute. May, 2004, http://www.nhlbi.nih.gov/resources/docs/cht-book.htm
- Halpern M T, Stanford R H, Borker R. The burden of COPD in the U.S.A.: results from the Confronting COPD Survey. Respir Med 2003; 97(Suppl C)81–89, [CROSSREF], [CSA]
- U.S. Bureau of Labor Statistics, Division of Consumer Prices and Price Indexes. Consumer Price Indexes (CPI). U S Department of Labor. 2006, [cited 2006 Jan]; http://www.bls.gov/cpi/home.htm
- Hilleman D E, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 2000; 118(5)1278–1285, [INFOTRIEVE], [CROSSREF], [CSA]
- Grasso M E, Weller W E, Shaffer T J, Diette G B, Anderson G F. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(1)133–138, [INFOTRIEVE], [CSA]
- Chapman K R, Mannino D M, Soriano J B, Vermeire P A, Buist A S, Thun M J, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27(1)188–207, [INFOTRIEVE], [CROSSREF], [CSA]
- Wilson L, Devine E B, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med 2000; 94(3)204–213, [INFOTRIEVE], [CROSSREF], [CSA]
- Leigh J P, Romano P S, Schenker M B, Kreiss K. Costs of occupational COPD and asthma. Chest 2002; 121(1)264–272, [INFOTRIEVE], [CROSSREF], [CSA]
- Cost-Effectiveness in Health and Medicine, M R Gold, J E Siegel, L B Russell, M C Weinstein. Oxford University Press, New York 1996
- Ward M M, Javitz H S, Smith W M, Bakst A. Direct medical costs of chronic obstructive pulmonary disease in the U.S.A. Respir Med 2000; 94(11)1123–1129, [INFOTRIEVE], [CROSSREF], [CSA]
- Stuart B, Doshi J A, Briesacher B, Wrobel M V, Baysac F. Impact of prescription coverage on hospital and physician costs: a case study of Medicare beneficiaries with chronic obstructive pulmonary disease. Clin Ther 2004; 26(10)1688–1699, [INFOTRIEVE], [CROSSREF], [CSA]
- Sullivan S D, Ramsey S D, Lee T A. The economic burden of COPD. Chest 2000; 117(2 Suppl.)5S–9S, [INFOTRIEVE], [CROSSREF], [CSA]
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt. 2)77–121, [CSA]
- Strassels S A, Smith D H, Sullivan S D, Mahajan P S. The costs of treating COPD in the United States. Chest 2001; 119(2)344–352, [INFOTRIEVE], [CROSSREF], [CSA]
- Mapel D W, Hurley J S, Frost F J, Petersen H V, Picchi M A, Coultas D B. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 2000; 160(17)2653–2658, [INFOTRIEVE], [CROSSREF], [CSA]
- Faulkner M A, Hilleman D E. The economic impact of chronic obstructive pulmonary disease. Expert Opin Pharmacother 2002; 3(3)219–228, [INFOTRIEVE], [CROSSREF], [CSA]
- Zuvekas S H, Cohen J W. A guide to comparing health care expenditures in the 1996 MEPS to the 1987 NMES. Inquiry 2002; 39(1)76–86, [INFOTRIEVE], [CSA]
- Sin D D, Stafinski T, Ng Y C, Bell N R, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 2002; 165(5)704–707, [INFOTRIEVE], [CSA]
- Ward M M, Javitz H S, Smith W M, Whan M A. Lost income and work limitations in persons with chronic respiratory disorders. J Clin Epidemiol 2002; 55(3)260–268, [INFOTRIEVE], [CROSSREF], [CSA]
- Saint S, Flaherty K R, Abrahamse P, Martinez F J, Fendrick A M. Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy. Clin Ther 2001; 23(3)499–512, [INFOTRIEVE], [CROSSREF], [CSA]
- Halpern M T, Higashi M K, Bakst A W, Schmier J K. The economic impact of acute exacerbations of chronic bronchitis in the United States and Canada: a literature review. J Manag Care Pharm 2003; 9(4)353–359, [INFOTRIEVE], [CSA]
- Halpern M T, Polzin J, Higashi M K, Bakst A. The workplace impact of acute exacerbations of chronic bronchitis (AECB): a literature review. COPD 2004; 1(2)249–254, [CSA]
- Niederman M S, McCombs J S, Unger A N, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther 1999; 21(3)576–591, [INFOTRIEVE], [CROSSREF], [CSA]
- Mapel D, Chen J C, George D, Halbert R J. The cost of chronic obstructive pulmonary disease and its effects on managed care. Manag Care Interface 2004; 17(4)61–66, [INFOTRIEVE], [CSA]
- Sin D D, McAlister F A, Man S F, Anthonisen N R. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003; 290(17)2301–2312, [INFOTRIEVE], [CROSSREF], [CSA]
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: Executive Summary Updated 2005. Global Initiative for Chronic Obstructive Lung Disease, [cited 2005 Nov 1]; www.goldcopd.org
- Joyce G F, Keeler E B, Shang B, Goldman D P. The Lifetime Burden of Chronic Disease Among the Elderly. Health Aff (Millwood). Sep 26, 2005
- U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). National Center for Health Statistics. National Health Promotion and Disease Prevention Objectives: Final Review. Oct, 2001, Healthy People 2000, Report No.: 76-641496